The incidence and cost of adverse events in Victorian hospitals 2003-2004

被引:111
作者
Ehsani, Jonathon P.
Jackson, Terri [1 ]
Duckett, Stephen J.
机构
[1] La Trobe Univ, Sch Publ Hlth, Bundoora, Vic 3083, Australia
[2] Dept Human Serv, Melbourne, Vic, Australia
关键词
D O I
10.5694/j.1326-5377.2006.tb00378.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine the incidence of adverse events in patients admitted in the year 2003-04 to selected Victorian hospitals; to identify the main hospital-acquired diagnoses; and to estimate the cost of these complications to the Victorian and Australian health system. Design: The patient-level costing dataset for major Victorian public hospitals, 1 July 2003 - 30 June 2004, was analysed for adverse events by identifying C-prefixed diagnosis codes denoting complications, preventable or otherwise, arising during the course of hospital treatment. The in-hospital cost of adverse events was estimated using linear regression modelling, adjusting for age and comorbidity. Main outcome measures: Cost of each patient admission ("admitted episode"), length of stay and mortality. Results: During the designated timeframe, 979834 admitted episodes were in the sample, of which 67 435 (6.88%) had at least one adverse event. Patients with adverse events stayed about 10 days longer and had over seven times the risk of in-hospital death than those without complications. After adjusting for age and comorbidity, the presence of an adverse event adds $6826 to the cost of each admitted episode. The total cost of adverse events in this dataset in 2003-04 was $460.311 million, representing 15.7% of the total expenditure on direct hospital costs, or an additional 18.6% of the total inpatient hospital budget. Conclusion: Adverse events are associated with significant costs. Administrative datasets are a cost-effective source of information that can be used for a range of clinical governance activities to prevent adverse events.
引用
收藏
页码:551 / 555
页数:5
相关论文
共 26 条
[1]  
*AUSTR COUNC SAF Q, LIST TERMS DEF SAF Q
[2]   Safety and quality in Australian healthcare: making progress [J].
Barraclough, BH .
MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (12) :616-617
[3]   The costs of adverse drug events in hospitalized patients [J].
Bates, DW ;
Spell, N ;
Cullen, DJ ;
Burdick, E ;
Laird, N ;
Petersen, LA ;
Small, SD ;
Sweitzer, BJ ;
Leape, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :307-311
[4]  
*BUND HOSP COMM IN, 2005, SAF QUAL
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]  
Douglas N., 2001, INQUIRY OBSTET GYNAE
[7]   Three Australian whistleblowing sagas: lessons for internal and external regulation [J].
Faunce, TA ;
Bolsin, SNC .
MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (01) :44-47
[8]   A comparison of two comorbidity instruments in arthritis [J].
Gabriel, SE ;
Crowson, CS ;
O'Fallon, WM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (12) :1137-1142